Related Experiment Video
Updated: May 11, 2026
07:12
Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
Published on: September 27, 2021
Vaginal films for drug delivery
Rita M Machado1, Ana Palmeira-de-Oliveira, José Martinez-De-Oliveira
1CICS-UBI, Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã 6200-506, Portugal.
Journal of Pharmaceutical Sciences
|May 8, 2013
Summary
Vaginal films offer an improved drug delivery system, overcoming limitations of traditional forms. These bioadhesive systems are promising for various therapeutic and prophylactic applications in women's health.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Gynecological Therapeutics
Background:
- The vagina offers advantages for drug delivery, including a large surface area, rich blood supply, and avoidance of first-pass metabolism.
- Traditional vaginal dosage forms often suffer from poor residence time and user discomfort.
- Novel drug delivery systems, especially bioadhesive polymers, are emerging to overcome these limitations.
Purpose of the Study:
- To review the potential of vaginal films as an advanced drug delivery system.
- To highlight the advantages of vaginal films over conventional dosage forms.
- To explore the therapeutic and prophylactic applications of vaginal films.
Main Methods:
- Review of existing literature on vaginal drug delivery systems.
- Analysis of the properties and manufacturing considerations of vaginal films.
- Evaluation of user acceptability studies for vaginal films.
Main Results:
- Vaginal films are solid dosage forms that dissolve upon contact with vaginal fluids, minimizing leakage and messiness.
- These films have shown potential for contraceptive, antimicrobial, and microbicide effects.
- Manufacturing and characterization require precise processes, but user acceptability studies are promising.
Conclusions:
- Vaginal films represent a significant advancement in vaginal drug delivery, offering improved patient compliance and efficacy.
- They provide a versatile platform for both therapeutic and prophylactic interventions in women's health.
- Further development and consideration of vaginal films are recommended for new drug delivery system designs.
More Related Videos
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.